Cargando…

Monocytes subsets altered distribution and dysregulated plasma hsa-miR-21-5p and hsa-miR-155-5p in HCV-linked liver cirrhosis progression to hepatocellular carcinoma

PURPOSE: The authors aim to investigate the altered monocytes subsets distribution in liver cirrhosis (LC) and subsequent hepatocellular carcinoma (HCC) in association with the expression level of plasma Homo sapiens (has)-miR-21-5p and hsa-miR-155-5p. A step toward non-protein coding (nc) RNA preci...

Descripción completa

Detalles Bibliográficos
Autores principales: Hammad, Reham, Eldosoky, Mona A., Elmadbouly, Asmaa A., Aglan, Reda Badr, AbdelHamid, Sherihan G., Zaky, Samy, Ali, Elham, Abd El Hakam, Fatma El-Zahraa, Mosaad, Alshaimaa M., Abdelmageed, Neamat A., Kotb, Fatma M., Kotb, Hend G., Hady, Ahmed A., Abo-Elkheir, Omaima I., Kujumdshiev, Sandy, Sack, Ulrich, Lambert, Claude, Hamdy, Nadia M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10620275/
https://www.ncbi.nlm.nih.gov/pubmed/37639012
http://dx.doi.org/10.1007/s00432-023-05313-w
_version_ 1785130172981182464
author Hammad, Reham
Eldosoky, Mona A.
Elmadbouly, Asmaa A.
Aglan, Reda Badr
AbdelHamid, Sherihan G.
Zaky, Samy
Ali, Elham
Abd El Hakam, Fatma El-Zahraa
Mosaad, Alshaimaa M.
Abdelmageed, Neamat A.
Kotb, Fatma M.
Kotb, Hend G.
Hady, Ahmed A.
Abo-Elkheir, Omaima I.
Kujumdshiev, Sandy
Sack, Ulrich
Lambert, Claude
Hamdy, Nadia M.
author_facet Hammad, Reham
Eldosoky, Mona A.
Elmadbouly, Asmaa A.
Aglan, Reda Badr
AbdelHamid, Sherihan G.
Zaky, Samy
Ali, Elham
Abd El Hakam, Fatma El-Zahraa
Mosaad, Alshaimaa M.
Abdelmageed, Neamat A.
Kotb, Fatma M.
Kotb, Hend G.
Hady, Ahmed A.
Abo-Elkheir, Omaima I.
Kujumdshiev, Sandy
Sack, Ulrich
Lambert, Claude
Hamdy, Nadia M.
author_sort Hammad, Reham
collection PubMed
description PURPOSE: The authors aim to investigate the altered monocytes subsets distribution in liver cirrhosis (LC) and subsequent hepatocellular carcinoma (HCC) in association with the expression level of plasma Homo sapiens (has)-miR-21-5p and hsa-miR-155-5p. A step toward non-protein coding (nc) RNA precision medicine based on the immune perturbation manifested as altered monocytes distribution, on top of LC and HCC. METHODS: Seventy-nine patients diagnosed with chronic hepatitis C virus (CHCV) infection with LC were enrolled in the current study. Patients were sub-classified into LC group without HCC (n = 40), LC with HCC (n = 39), and 15 apparently healthy controls. Monocyte subsets frequencies were assessed by flow cytometry. Real-time quantitative PCR was used to measure plasma hsa-miR-21-5p and hsa-miR-155-5p expression. RESULTS: Hsa-miR-21-5p correlated with intermediate monocytes (r = 0.30, p = 0.007), while hsa-miR-155-5p negatively correlated with non-classical monocytes (r = − 0.316, p = 0.005). ROC curve analysis revealed that combining intermediate monocytes frequency and hsa-miR-21 yielded sensitivity = 79.5%, specificity = 75%, and AUC = 0.84. In comparison, AFP yielded a lower sensitivity = 69% and 100% specificity with AUC = 0.85. Logistic regression analysis proved that up-regulation of intermediate monocytes frequency and hsa-miR-21-5p were independent risk factors for LC progression to HCC, after adjustment for co-founders. CONCLUSION: Monocyte subsets differentiation in HCC was linked to hsa-miR-21-5p and hsa-miR-155-5p. Combined up-regulation of intermediate monocytes frequency and hsa-miR-21-5p expression could be considered a sensitive indicator of LC progression to HCC. Circulating intermediate monocytes and hsa-miR-21-5p were independent risk factors for HCC evolution, clinically and in silico proved. GRAPHICAL ABSTRACT: [Image: see text] SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s00432-023-05313-w.
format Online
Article
Text
id pubmed-10620275
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Springer Berlin Heidelberg
record_format MEDLINE/PubMed
spelling pubmed-106202752023-11-03 Monocytes subsets altered distribution and dysregulated plasma hsa-miR-21-5p and hsa-miR-155-5p in HCV-linked liver cirrhosis progression to hepatocellular carcinoma Hammad, Reham Eldosoky, Mona A. Elmadbouly, Asmaa A. Aglan, Reda Badr AbdelHamid, Sherihan G. Zaky, Samy Ali, Elham Abd El Hakam, Fatma El-Zahraa Mosaad, Alshaimaa M. Abdelmageed, Neamat A. Kotb, Fatma M. Kotb, Hend G. Hady, Ahmed A. Abo-Elkheir, Omaima I. Kujumdshiev, Sandy Sack, Ulrich Lambert, Claude Hamdy, Nadia M. J Cancer Res Clin Oncol Research PURPOSE: The authors aim to investigate the altered monocytes subsets distribution in liver cirrhosis (LC) and subsequent hepatocellular carcinoma (HCC) in association with the expression level of plasma Homo sapiens (has)-miR-21-5p and hsa-miR-155-5p. A step toward non-protein coding (nc) RNA precision medicine based on the immune perturbation manifested as altered monocytes distribution, on top of LC and HCC. METHODS: Seventy-nine patients diagnosed with chronic hepatitis C virus (CHCV) infection with LC were enrolled in the current study. Patients were sub-classified into LC group without HCC (n = 40), LC with HCC (n = 39), and 15 apparently healthy controls. Monocyte subsets frequencies were assessed by flow cytometry. Real-time quantitative PCR was used to measure plasma hsa-miR-21-5p and hsa-miR-155-5p expression. RESULTS: Hsa-miR-21-5p correlated with intermediate monocytes (r = 0.30, p = 0.007), while hsa-miR-155-5p negatively correlated with non-classical monocytes (r = − 0.316, p = 0.005). ROC curve analysis revealed that combining intermediate monocytes frequency and hsa-miR-21 yielded sensitivity = 79.5%, specificity = 75%, and AUC = 0.84. In comparison, AFP yielded a lower sensitivity = 69% and 100% specificity with AUC = 0.85. Logistic regression analysis proved that up-regulation of intermediate monocytes frequency and hsa-miR-21-5p were independent risk factors for LC progression to HCC, after adjustment for co-founders. CONCLUSION: Monocyte subsets differentiation in HCC was linked to hsa-miR-21-5p and hsa-miR-155-5p. Combined up-regulation of intermediate monocytes frequency and hsa-miR-21-5p expression could be considered a sensitive indicator of LC progression to HCC. Circulating intermediate monocytes and hsa-miR-21-5p were independent risk factors for HCC evolution, clinically and in silico proved. GRAPHICAL ABSTRACT: [Image: see text] SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s00432-023-05313-w. Springer Berlin Heidelberg 2023-08-28 2023 /pmc/articles/PMC10620275/ /pubmed/37639012 http://dx.doi.org/10.1007/s00432-023-05313-w Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Research
Hammad, Reham
Eldosoky, Mona A.
Elmadbouly, Asmaa A.
Aglan, Reda Badr
AbdelHamid, Sherihan G.
Zaky, Samy
Ali, Elham
Abd El Hakam, Fatma El-Zahraa
Mosaad, Alshaimaa M.
Abdelmageed, Neamat A.
Kotb, Fatma M.
Kotb, Hend G.
Hady, Ahmed A.
Abo-Elkheir, Omaima I.
Kujumdshiev, Sandy
Sack, Ulrich
Lambert, Claude
Hamdy, Nadia M.
Monocytes subsets altered distribution and dysregulated plasma hsa-miR-21-5p and hsa-miR-155-5p in HCV-linked liver cirrhosis progression to hepatocellular carcinoma
title Monocytes subsets altered distribution and dysregulated plasma hsa-miR-21-5p and hsa-miR-155-5p in HCV-linked liver cirrhosis progression to hepatocellular carcinoma
title_full Monocytes subsets altered distribution and dysregulated plasma hsa-miR-21-5p and hsa-miR-155-5p in HCV-linked liver cirrhosis progression to hepatocellular carcinoma
title_fullStr Monocytes subsets altered distribution and dysregulated plasma hsa-miR-21-5p and hsa-miR-155-5p in HCV-linked liver cirrhosis progression to hepatocellular carcinoma
title_full_unstemmed Monocytes subsets altered distribution and dysregulated plasma hsa-miR-21-5p and hsa-miR-155-5p in HCV-linked liver cirrhosis progression to hepatocellular carcinoma
title_short Monocytes subsets altered distribution and dysregulated plasma hsa-miR-21-5p and hsa-miR-155-5p in HCV-linked liver cirrhosis progression to hepatocellular carcinoma
title_sort monocytes subsets altered distribution and dysregulated plasma hsa-mir-21-5p and hsa-mir-155-5p in hcv-linked liver cirrhosis progression to hepatocellular carcinoma
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10620275/
https://www.ncbi.nlm.nih.gov/pubmed/37639012
http://dx.doi.org/10.1007/s00432-023-05313-w
work_keys_str_mv AT hammadreham monocytessubsetsaltereddistributionanddysregulatedplasmahsamir215pandhsamir1555pinhcvlinkedlivercirrhosisprogressiontohepatocellularcarcinoma
AT eldosokymonaa monocytessubsetsaltereddistributionanddysregulatedplasmahsamir215pandhsamir1555pinhcvlinkedlivercirrhosisprogressiontohepatocellularcarcinoma
AT elmadboulyasmaaa monocytessubsetsaltereddistributionanddysregulatedplasmahsamir215pandhsamir1555pinhcvlinkedlivercirrhosisprogressiontohepatocellularcarcinoma
AT aglanredabadr monocytessubsetsaltereddistributionanddysregulatedplasmahsamir215pandhsamir1555pinhcvlinkedlivercirrhosisprogressiontohepatocellularcarcinoma
AT abdelhamidsherihang monocytessubsetsaltereddistributionanddysregulatedplasmahsamir215pandhsamir1555pinhcvlinkedlivercirrhosisprogressiontohepatocellularcarcinoma
AT zakysamy monocytessubsetsaltereddistributionanddysregulatedplasmahsamir215pandhsamir1555pinhcvlinkedlivercirrhosisprogressiontohepatocellularcarcinoma
AT alielham monocytessubsetsaltereddistributionanddysregulatedplasmahsamir215pandhsamir1555pinhcvlinkedlivercirrhosisprogressiontohepatocellularcarcinoma
AT abdelhakamfatmaelzahraa monocytessubsetsaltereddistributionanddysregulatedplasmahsamir215pandhsamir1555pinhcvlinkedlivercirrhosisprogressiontohepatocellularcarcinoma
AT mosaadalshaimaam monocytessubsetsaltereddistributionanddysregulatedplasmahsamir215pandhsamir1555pinhcvlinkedlivercirrhosisprogressiontohepatocellularcarcinoma
AT abdelmageedneamata monocytessubsetsaltereddistributionanddysregulatedplasmahsamir215pandhsamir1555pinhcvlinkedlivercirrhosisprogressiontohepatocellularcarcinoma
AT kotbfatmam monocytessubsetsaltereddistributionanddysregulatedplasmahsamir215pandhsamir1555pinhcvlinkedlivercirrhosisprogressiontohepatocellularcarcinoma
AT kotbhendg monocytessubsetsaltereddistributionanddysregulatedplasmahsamir215pandhsamir1555pinhcvlinkedlivercirrhosisprogressiontohepatocellularcarcinoma
AT hadyahmeda monocytessubsetsaltereddistributionanddysregulatedplasmahsamir215pandhsamir1555pinhcvlinkedlivercirrhosisprogressiontohepatocellularcarcinoma
AT aboelkheiromaimai monocytessubsetsaltereddistributionanddysregulatedplasmahsamir215pandhsamir1555pinhcvlinkedlivercirrhosisprogressiontohepatocellularcarcinoma
AT kujumdshievsandy monocytessubsetsaltereddistributionanddysregulatedplasmahsamir215pandhsamir1555pinhcvlinkedlivercirrhosisprogressiontohepatocellularcarcinoma
AT sackulrich monocytessubsetsaltereddistributionanddysregulatedplasmahsamir215pandhsamir1555pinhcvlinkedlivercirrhosisprogressiontohepatocellularcarcinoma
AT lambertclaude monocytessubsetsaltereddistributionanddysregulatedplasmahsamir215pandhsamir1555pinhcvlinkedlivercirrhosisprogressiontohepatocellularcarcinoma
AT hamdynadiam monocytessubsetsaltereddistributionanddysregulatedplasmahsamir215pandhsamir1555pinhcvlinkedlivercirrhosisprogressiontohepatocellularcarcinoma